Summary
Johnson & Johnson (JNJ) announced on November 30, 2023, the acquisition of Laminar, Inc. This strategic move, categorized as an asset acquisition, will result in an in-process research and development charge. Consequently, JNJ is revising its Adjusted Earnings Per Share (EPS) guidance for the fiscal year 2023. The company now anticipates Adjusted EPS to be between $9.85 to $9.91 on an operational basis and $9.90 to $9.96 on a reported basis. This reflects a reduction of approximately $0.17 from previously issued guidance due to the acquisition-related charge. Furthermore, the acquisition is projected to have a negative EPS impact of approximately $0.15 in fiscal year 2024.
Key Highlights
- 1JNJ has acquired Laminar, Inc., marking a new strategic development.
- 2The acquisition necessitates an in-process research and development charge.
- 3Fiscal Year 2023 Adjusted EPS guidance has been lowered by approximately $0.17 due to the charge.
- 4Revised FY2023 operational Adjusted EPS guidance is $9.85 - $9.91.
- 5Revised FY2023 reported Adjusted EPS guidance is $9.90 - $9.96.
- 6The acquisition is expected to negatively impact FY2024 EPS by approximately $0.15.